BridgeMD
New treatment option for Video-assisted Thoracoscopic Lung Surgery；Anesthesia
Official title Opioid-Free Combined Anesthesia With Spontaneous Breathing for VATS
ClinicalTrials.gov ID: NCT06367218
What this study is testing
What is opioid based strategy?
opioid based strategy is an investigational medicine, being studied as a potential treatment for video-assisted thoracoscopic lung surgery；anesthesia.
Plain-language explanation of the investigational treatment - it is being studied and is not an approved or proven therapy. The study team can confirm the details.
- What it's testing
- Non-tracheal intubated combined anesthesia with preserved spontaneous breathing significantly enhances the quality and speed of recovery post-VATS for patients undergoing lung nodule surgery. The "opioid-sparing strategy," which substitutes ketamine for opioids during surgery, not only provides effective analgesia but also protects perioperative lung function and reasonably prevents the occurrence of opioid-related adverse reactions; it also reduces medical costs and shortens the average hospital stay.
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 to 70
You may be able to join if
- ASA grades 1-2
- Age \> 18 years and \< 70 years
- Male or female patients
- VATS pulmonary nodule operation is planned under general anesthesia
- Voluntarily participate in the study and sign the informed consent
You likely can't join if
- Subject's operation is aborted
- Serious adverse events, complications or special physiological changes during the perioperative period should not be continued
- Expansion of surgical scope: resection of complex lung segment or complex lung lobectomy, thoracoscopic assisted small-incision surgery with enlarged...
- Those who need a second operation within a month
- The patient or his/her guardian requests to withdraw on his/her own
- Reasons why other researchers think the study needs to be discontinued
The study team makes the final eligibility decision.
Where it's taking place
- Wuhan, Hubei, China
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years to 70 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Wuhan, Hubei, China. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.